Prevention of Postoperative Events Following Reversal With Sugammadex or Neostigmine

NCT02825576 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

30

Enrollment

OTHER

Sponsor class

Stopped Lack of Study Personnel

Conditions

Pulmonary Complications

Interventions

DRUG: Sugammadex
DRUG: Neostigmine/Glycopyrrolate

Sponsor

Northern Sydney Anaesthesia Research Institute

Collaborators

[object Object]
[object Object]